A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of Relative Bioavailability of TAK-788 Capsules in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 28, 2018

Primary Completion Date

December 22, 2018

Study Completion Date

January 18, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-788

TAK-788 capsules.

DRUG

Placebo

TAK-788 placebo-matching capsules.

DRUG

TAK-788

TAK-788 DiC.

Trial Locations (1)

PRA Health Sciences, Salt Lake City